Company profile: QOL Medical
1.1 - Company Overview
Company description
- Provider of specialty biopharmaceutical products and services.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to QOL Medical
89bio
HQ: United States
Website
- Description: Provider of biologic and small molecule therapies for liver and metabolic disorders, developing pegozafermin for MASH to reduce liver fibrosis and for severe hypertriglyceridemia to lower triglyceride levels and address lipid metabolism imbalance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full 89bio company profile →
Enobia Pharma
HQ: Canada
Website
- Description: Provider of therapies for serious genetic bone disorders, focused on conditions with no approved treatments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Enobia Pharma company profile →
Jecure Therapeutics
HQ: United States
Website
- Description: Provider of research and development focused on the discovery of innovative therapeutics for the treatment of non-alcoholic steatohepatitis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Jecure Therapeutics company profile →
Metacrine
HQ: United States
Website
- Description: Provider of clinical-stage biopharmaceutical research and development focused on building an innovative pipeline of best-in-class drugs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Metacrine company profile →
BarioSurg
HQ: United States
Website
- Description: Provider of a proprietary, long-term, minimally invasive and reversible medical device, the Gastric Vest System, for bariatric surgeons to address obesity and metabolic disease.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BarioSurg company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for QOL Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to QOL Medical
2.2 - Growth funds investing in similar companies to QOL Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for QOL Medical
4.2 - Public trading comparable groups for QOL Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →